Real-Time Oncology Review Pilot Program
OCE Real-Time Oncology Review
Related Articles
A Unified Approach to Health Data Exchange
This Special Communication outlines the ways in which the US Department of Health and Human Services has worked to use electronic health record data to…
OCE ENGAGE: A Project Community Newsletter
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers
FDA approves sotorasib with panitumumab for colorectal cancer
On Jan. 15, 2025, the FDA approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for KRAS G12C-mutated metastatic colorectal cancer.
OCE Conversations on Cancer – Introducing Project Connect: A World-Wide Forum for Patients with Cancer
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology
OCE ENGAGE: A Project Community Newsletter
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers
FDA approves sotorasib with panitumumab for colorectal cancer
On Jan. 15, 2025, the FDA approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for KRAS G12C-mutated metastatic colorectal cancer.
FDA approves sotorasib with panitumumab for colorectal cancer
On Jan. 15, 2025, the FDA approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for KRAS G12C-mutated metastatic colorectal cancer.
Oncology Center of Excellence Guidance Documents
Recently added guidance documents regarding oncology and malignant hematology